• Several positive immune regulatorshave been provedto improve survival in animal models of GBM. CD137 (4-1BB), when usedalong with anti-CTLA-4 antibody and radiation therapy, assists T cell proliferation and escalates survival in GBMmurine models, likely by increasing immune activity against tumors. Here, CTLA4 is linked to glioblastoma.